These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 24329899)
1. Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice. Muirhead N; Zaltman JS; Gill JS; Churchill DN; Poulin-Costello M; Mann V; Cole EH Clin Transplant; 2014 Feb; 28(2):161-5. PubMed ID: 24329899 [TBL] [Abstract][Full Text] [Related]
2. Mineral metabolism in renal transplant recipients discontinuing cinacalcet at the time of transplantation: a prospective observational study. Evenepoel P; Sprangers B; Lerut E; Bammens B; Claes K; Kuypers D; Meijers B; Vanrenterghem Y Clin Transplant; 2012; 26(3):393-402. PubMed ID: 22007637 [TBL] [Abstract][Full Text] [Related]
3. Near total parathyroidectomy is effective therapy for tertiary hyperparathyroidism. Dewberry LK; Weber C; Sharma J Am Surg; 2014 Jul; 80(7):646-51. PubMed ID: 24987894 [TBL] [Abstract][Full Text] [Related]
4. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Borchhardt KA; Heinzl H; Mayerwöger E; Hörl WH; Haas M; Sunder-Plassmann G Transplantation; 2008 Oct; 86(7):919-24. PubMed ID: 18852656 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Serra AL; Schwarz AA; Wick FH; Marti HP; Wüthrich RP Nephrol Dial Transplant; 2005 Jul; 20(7):1315-9. PubMed ID: 15941845 [TBL] [Abstract][Full Text] [Related]
6. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism. Schwarz A; Merkel S; Leitolf H; Haller H Transplantation; 2011 Mar; 91(5):560-5. PubMed ID: 21192318 [TBL] [Abstract][Full Text] [Related]
7. Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism. Bergua C; Torregrosa JV; Cofán F; Oppenheimer F Transplant Proc; 2007 Sep; 39(7):2254-5. PubMed ID: 17889155 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological analysis of persistent hypercalcemia and hyperparathyroidism after kidney transplantation in long-term dialysis patients. Nakamura M; Tanaka K; Marui Y; Tomikawa S Ther Apher Dial; 2013 Oct; 17(5):551-6. PubMed ID: 24107283 [TBL] [Abstract][Full Text] [Related]
10. Management of hypercalcemia after renal transplantation. Torregrosa JV; Barros X Nefrologia; 2013 Nov; 33(6):751-7. PubMed ID: 24241361 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients. Sutton W; Chen X; Patel P; Karzai S; Prescott JD; Segev DL; McAdams-DeMarco M; Mathur A Surgery; 2022 Jan; 171(1):69-76. PubMed ID: 34266650 [TBL] [Abstract][Full Text] [Related]
12. Risk factors of post renal transplant hyperparathyroidism. Hamidian Jahromi A; Roozbeh J; Raiss-Jalali GA; Dabaghmanesh A; Jalaeian H; Bahador A; Nikeghbalian S; Salehipour M; Salahi H; Malek-Hosseini A Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):573-6. PubMed ID: 19587496 [TBL] [Abstract][Full Text] [Related]
13. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal. Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597 [TBL] [Abstract][Full Text] [Related]
14. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Souqiyyeh MZ; Shaheen FA Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700 [TBL] [Abstract][Full Text] [Related]
15. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study. Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965 [TBL] [Abstract][Full Text] [Related]
16. Natural History of Serum Calcium and Parathyroid Hormone Following Renal Transplantation. Al-Moasseb Z; Aitken E Transplant Proc; 2016 Dec; 48(10):3285-3291. PubMed ID: 27931570 [TBL] [Abstract][Full Text] [Related]
17. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. Wolf M; Weir MR; Kopyt N; Mannon RB; Von Visger J; Deng H; Yue S; Vincenti F Transplantation; 2016 Jan; 100(1):184-93. PubMed ID: 26177089 [TBL] [Abstract][Full Text] [Related]
18. Predictors of tertiary hyperparathyroidism: Who will benefit from parathyroidectomy? Dewberry LC; Tata S; Graves S; Weber CJ; Sharma J Surgery; 2014 Dec; 156(6):1631-6; discussion 1636-7. PubMed ID: 25456966 [TBL] [Abstract][Full Text] [Related]
19. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Rostaing L; Moreau-Gaudry X; Baron E; Cisterne JM; Monroziès-Bernadet P; Durand D Clin Nephrol; 1997 Apr; 47(4):248-55. PubMed ID: 9128792 [TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of a 3-Year Therapy With Cinacalcet in Persistent Hyperparathyroidism After Renal Transplant. Rivelli GG; Lopes de Lima M; Mazzali M Transplant Proc; 2020 Jun; 52(5):1284-1286. PubMed ID: 32204903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]